Mari-Lynn Drainoni, PhD, MEd
Research Professor, Medicine
Biography
Mari-Lynn Drainoni, M.Ed., Ph.D., is Research Professor in the Section of Infectious Diseases in the School of Medicine in the Chobanian and Avedisian School of Medicine and in the Department of Health Law, Policy & Management at the Boston University School of Public Health. She is also Co-Director of the Evans Center for Implementation and Improvement Sciences at Boston University. Dr. Drainoni’s areas of expertise include the conduct of implementation research, qualitative research methods and mixed method studies with a focus on integrating research into practice. Her specific studies have focused on the content areas of infectious diseases, including HIV/AIDS and hepatitis C, as well as substance use, antibiotic prescribing and antibiotic stewardship, and integrating screening for social determinants of health into clinical practice. Dr. Drainoni has conducted numerous implementation studies to integrate research into practice, studies evaluating demonstration programs for at-risk populations, and mixed methods studies that include both surveys involving primary data collection and qualitative data collection and analysis. Some of her current research projects include: 1) an AHRQ-funded study evaluating alternative implementation strategies for antibiotic stewardship in two large inpatient hospital systems across the US; 2) a HRSA-funded study to implement and evaluate the use of community health workers to improve retention and outcomes in clinical care for persons living with HIV in 10 sites across the US; 3) a NIDA-funded study to examine police-led models of engaging people in treatment for opioid addiction in Massachusetts; 4) serving as the Implementation Science Core Director of the Healing Communities Study, a NIDA/SAMHSA-funded study in four states to implement and evaluate interventions designed to reduce overdose deaths; 5) an NHLBI-funded project to assess the implementation of a social determinants of health screening and referral intervention for children with sickle cell anemia; 6) a study of the uptake of rapid diagnostic tests for infectious disease and behavioral factors influencing use of rapid diagnostic tests; 7) an NICHD-funded study to test and implement an intervention designed to screen for social determinants of health and unmet material needs in pediatric practices across the US; 8) a VA-funded initiative to implement and evaluate a peer intervention for veterans leaving incarceration; 9) an American Cancer Society-funded study evaluating an intervention designed to improve offering the HPV vaccine in community health centers; and 10) leading the implementation science component of a PCORI-funded study to compare two brief interventions within the primary care medical home to assess the most effective strategy to improve outcomes among pregnant and postpartum women with depressive symptoms, assess the optimal time to deploy each strategy and examine the barriers to establishing these interventions. Dr. Drainoni also is the Implementation Science Lead on the Providence-Boston Center for AIDS Research (CFAR), Implementation Science Lead on the Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV, and Principal Investigator on the Boston University School of Public Health NIDA-funded T32, Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE).
Other Positions
- Research Professor, Health Law, Policy & Management, Boston University School of Public Health
- Co-Director, Evans Center for Implementation & Improvement Sciences, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
Education
- Northeastern University, PhD
- University of Massachusetts Boston, MEd
- Tufts University, BA
Publications
- Published on 6/19/2024
Cohen RT, Burrowes SAB, Williams CJ, Neri CM, Klings ES, Jones KC, Walkey AJ, Drainoni ML. SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team. Pediatr Blood Cancer. 2024 Jun 19; e31142. PMID: 38896013.
Read at: PubMed - Published on 6/16/2024
Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Munoz Lopez R, Nelson A, Neufeld JL, Newman L, Nguyen TQ, Nunes EV, Oller DA, Oser CB, Oyler DR, Pagnano S, Parran TV, Powell J, Powers K, Ralston W, Ramsey K, Rapkin BD, Reynolds JG, Roberts MF, Robertson W, Rock P, Rodgers E, Rodriguez S, Rudorf M, Ryan S, Salsberry P, Salvage M, Sabounchi N, Saucier M, Savitzky C, Schackman B, Schady E, Seiber EE, Shadwick A, Shoben A, Slater MD, Slavova S, Speer D, Sprunger J, Starbird LE, Staton M, Stein MD, Stevens-Watkins DJ, Stopka TJ, Sullivan A, Surratt HL, Sword Cruz R, Talbert JC, Taylor JL, Thompson KL, Vandergrift N, Vickers-Smith RA, Vietze DJ, Walker DM, Walley AY, Walters ST, Weiss R, Westgate PM, Wu E, Young AM, Zarkin GA, Walsh SL. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths. N Engl J Med. 2024 Jun 16. PMID: 38884347.
Read at: PubMed - Published on 6/8/2024
Knudsen HK, Walker DM, Mack N, Kinnard EN, Huerta TR, Glasgow L, Gilbert L, Garner BR, Dasgupta A, Chandler R, Walsh SL, Tin Y, Tan S, Sprunger J, Sprague-Martinez L, Salsberry P, Saucier M, Rudorf M, Rodriguez S, Oser CB, Oga E, Nakayima J, Linas BS, Lefebvre RC, Kosakowski S, Katz RE, Hunt T, Holman A, Holloway J, Goddard-Eckrich D, Fareed N, Christopher M, Aldrich A, Adams JW, Drainoni ML. Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term®) communities study. Prev Med. 2024 Jun 08; 185:108034. PMID: 38857770.
Read at: PubMed - Published on 5/21/2024
Silver SR, Jones KC, Hook K, Crable EL, George ER, Serwint JR, Austad K, Walkey A, Drainoni ML. Defining the transition from new to normal: a qualitative investigation of the clinical change process. Res Sq. 2024 May 21. PMID: 38826210.
Read at: PubMed - Published on 5/20/2024
Rudel RK, Byhoff E, Fielman SB, Strombotne KL, Drainoni ML, Greece JA. A Qualitative Study of A Health Center-Based Mobile Produce Market. J Ambul Care Manage. 2024 Jul-Sep 01; 47(3):134-142. PMID: 38771169.
Read at: PubMed - Published on 4/24/2024
Fletcher L, Burrowes S, Sabin LL, McCann N, Khan GK, Ruiz-Mercado G, Johnson S, Kimmel SD, Pierre C, Drainoni ML. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites. AIDS Patient Care STDS. 2024 May; 38(5):221-229. PMID: 38656905.
Read at: PubMed - Published on 4/12/2024
Rudel RK, Byhoff E, Strombotne KL, Drainoni ML, Greece JA. Factors Associated With Uptake of an Open Access Health Center-Based Mobile Produce Market: A Case for Expanded Eligibility. J Acad Nutr Diet. 2024 Apr 12. PMID: 38615994.
Read at: PubMed - Published on 4/9/2024
Berk J, Frank HE, Drainoni ML. Locked in and left out: the "prison penalty" for implementation of evidence-based interventions. Implement Sci Commun. 2024 Apr 09; 5(1):36. PMID: 38594784.
Read at: PubMed - Published on 2/23/2024
Byhoff E, LeClair AM, Smith CN, Roy TK, Drainoni ML. Designing an implementation strategy to increase health-related social needs screening: Applying the PRISM framework in a resource-limited clinical setting. Transl Behav Med. 2024 Feb 23; 14(3):197-205. PMID: 37897404.
Read at: PubMed - Published on 1/17/2024
Assoumou SA, Bonilla HV, Vautour L, White C, Read Newcomb A, Kibbe D, Goldie J, Merrill A, Monahan M, Linas BP, Drainoni ML, Pierre CM, Graham R. A Communications Campaign to Build Confidence in Covid-19 Vaccines: The Boston Medical Center Experience. NEJM Catal Innov Care Deliv. 2024 Feb; 5(2). PMID: 38813133.
Read at: PubMed
View 222 more publications: View full profile at BUMC